Loading…

Consumer Quality Index Chronic Skin Disease (CQI-CSD): a new instrument to measure quality of care from the patient's perspective

Summary Background Assessing quality of care from the patient's perspective is considered to be highly relevant. As a standardized instrument in dermatology was lacking, we developed a patient experience questionnaire regarding chronic skin disease care: the Consumer Quality Index Chronic Skin...

Full description

Saved in:
Bibliographic Details
Published in:British journal of dermatology (1951) 2015-10, Vol.173 (4), p.1032-1040
Main Authors: van Cranenburgh, O.D., Krol, M.W., Hendriks, M.C.P., de Rie, M.A., Smets, E.M.A., de Korte, J., Sprangers, M.A.G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background Assessing quality of care from the patient's perspective is considered to be highly relevant. As a standardized instrument in dermatology was lacking, we developed a patient experience questionnaire regarding chronic skin disease care: the Consumer Quality Index Chronic Skin Disease (CQI‐CSD). Objectives (i) To evaluate the dimensional structure of the CQI‐CSD, (ii) to assess its ability to distinguish between hospitals according to patients' experiences with quality of care, (iii) to explore patients' experiences with dermatological care and priorities for quality improvement according to the patients, and (iv) to optimize the questionnaire based on psychometric results and stakeholders' input. Methods In a cross‐sectional study 5647 adult patients who received dermatological care in the past 12 months in 20 hospitals were randomly selected and invited to fill out the questionnaire. Results Overall 1160 of 3989 eligible respondents (29% response rate, 30–87 per hospital) were included for analysis. The CQI‐CSD comprised seven scales with high internal consistency (Cronbach's α = 0·74–0·92). The instrument's discriminative power was limited. Patients were positive about the care provided by nurses and doctors, but the provision of information by healthcare providers, accessibility of care and patient involvement could be improved. We optimized the CQI‐CSD, resulting in a revised questionnaire containing 65 items. Conclusions In conclusion, the CQI‐CSD is a useful instrument to measure patient experiences with dermatological care. What's already known about this topic? To measure the quality of dermatological care, indicators based on expert consensus, clinical measures, patient satisfaction and quality of life are used. Patient experiences with care are of increasing importance in assessing the quality of health care. To date, no standardized instrument is available in dermatology. Information on patients' experiences may facilitate quality improvement by healthcare providers, and may help patients to choose an appropriate healthcare provider. What does this study add? We developed a useful questionnaire to assess patients' experiences with health care regarding chronic skin diseases involving all relevant stakeholders: patients, healthcare professionals and health insurers. This new questionnaire, Consumer Quality Index Chronic Skin Disease (CQI‐CSD), may be used by different stakeholders and for multiple purposes, for example by health
ISSN:0007-0963
1365-2133
DOI:10.1111/bjd.13957